Peptidoglycan synthesis enzyme

Peptidoglycan synthesis enzymes are a diverse group of bacterial proteins essential for constructing peptidoglycan, the major structural component of the bacterial cell wall[1][2][7]. These enzymes perform sequential reactions to build and remodel the peptidoglycan layer, including cytoplasmic synthesis of precursors by the Mur enzyme family, membrane-associated polymerization by glycosyltransferases (such as MurG, RodA), and the cross-linking of glycan strands by transpeptidases such as penicillin-binding proteins (PBPs)[2][3][5][8]. Inhibition of these enzymes by antibiotics like β-lactams (which block transpeptidase PBPs) and glycopeptides (which block glycan strand elongation) is a primary strategy in antibacterial therapy[6][7][9]. Many members of this enzyme group are major drug targets, but the broad term "peptidoglycan synthesis enzyme" encompasses several distinct targets; for structured data, specific enzymes such as "Transpeptidase (penicillin-binding protein 2)" or "MurG glycosyltransferase" should be named[2][3][6]. Notes on correctness: - The submitted name, "Bacterial cell wall peptidoglycan synthesis enzyme," is overly broad and not a conventional canonical name for a single therapeutic target. - Several specific enzymes participate in peptidoglycan synthesis, such as MurA-F (Mur family), PBPs, RodA, and MurG, each with their established canonical forms and molecular functions[2][3][8]. - For structured information, a specific enzyme or protein (e.g., "Penicillin-binding protein 2 (PBP2)" or "Glycosyltransferase MurG") should be selected. Summary: The peptidoglycan synthesis pathway is essential for bacterial viability, and its enzymes are key antibiotic targets[1][6][9]. Multiple distinct enzymes exist under this category, so the term as given is not fully correct as a single canonical target form.

Other names

Penicillin-binding protein (PBP)TransglycosylaseTranspeptidaseMur enzymes (MurA, MurB, MurC, MurD, MurE, MurF)RodASEDS protein familyGlycosyltransferase (MurG)FtsW

Inhibition of transpeptidase activity (e.g., by β-lactams), Inhibition of glycosyltransferase activity (e.g., by moenomycin), Inhibition of D-Ala-D-Ala binding (e.g., vancomycin), Inhibition of lipid carrier processing (e.g., bacitracin)